Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · cited 1×
“The KLK3 gene, encoding for PSA, is a kallikrein serine protease and used as a reference for relative biomarker quantitation using the DDCt method [22].”
MethodDeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341 · cited 1×
“Clinical utility was assessed with decision curve analysis (DCA) in R [24].”
MethodThompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051
Self-citationSTARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.246280 · Cited by 984
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer
Hessels, D., Klein Gunnewiek, J. M. T., van Oort, I., Karthaus, H. F. M., van Leenders, G. J. L., van Balken, B., Kiemeney, L. A., Witjes, J. A., & Schalken, J. A. (2003) · European Urology · doi:10.1016/s0302-2838(03)00201-x · Cited by 704
Self-citationWelch, H. G., & Albertsen, P. C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp278 · Cited by 575
APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer
Groskopf, J., Aubin, S. M., Deras, I. L., Blase, A., Bodrug, S., Clark, C., Brentano, S., Mathis, J., Pham, J., Meyer, T., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063289 · Cited by 529
PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy
Marks, L. S., Fradet, Y., Deras, I. L., et al. (2007) · Urology · doi:10.1016/j.urology.2006.12.014 · Cited by 447
Parekh, D. J., Punnen, S., Sjoberg, D. D., Asroff, S. W., Bailen, J. L., Cochran, J. S., Concepcion, R., David, R. D., Deck, K. B., Dumbadze, I., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.021 · Cited by 414
Serial Biopsy Results in Prostate Cancer Screening Study
ROEHL, K. A., ANTENOR, J. A. V., & CATALONA, W. J. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64999-3 · Cited by 362
Ankerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J., et al. (2014) · Urology · doi:10.1016/j.urology.2014.02.035 · Cited by 236 · cited 2×
“Patient management and risk assessment benefit from combining different complementary information sources into one coherent risk score because no single marker can obtain a similar performance on its own [19,20].”
BackgroundStewart, G. D., Van Neste, L., Delvenne, P., Delrée, P., Delga, A., McNeill, S. A., O'Donnell, M., Clark, J., Van Criekinge, W., Bigley, J., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.08.219 · Cited by 226
Self-citationIdentification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
Leyten, G. H. J. M., Hessels, D., Smit, F. P., Jannink, S. A., de Jong, H., Melchers, W. J. G., Cornel, E. B., de Reijke, T. M., Vergunst, H., Kil, P., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3334 · Cited by 221
Self-citationNordström, T., Vickers, A., Assel, M., Lilja, H., Grönberg, H., & Eklund, M. (2015) · European Urology · doi:10.1016/j.eururo.2014.08.010 · Cited by 217
Auprich, M., Chun, F. K. ‐., Ward, J. F., Pummer, K., Babaian, R. J., Augustin, H., Luger, F., Gutschi, S., Budäus, L., Fisch, M. M., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.10.024 · Cited by 147
Gittelman, M., Hertzman, B., Bailen, J. L., Williams, T., Koziol, I., Henderson, R. J., Efros, M. D., Bidair, M., & Ward, J. F. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.02.018 · Cited by 145
Braun, K., Sjoberg, D. D., Vickers, A. J., Lilja, H. G., & Bjartell, A. S. (2015) · European Urology · doi:10.1016/j.eururo.2015.04.028 · Cited by 104
Scattoni, V., Lazzeri, M., Giovanni Lughezzani, A., LUCA, S. D., Passera, R., Bollito, E., Randone, D. F., Abdollah, F., Umberto Capitanio, A., Larcher, A., et al. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.02.3184 · Cited by 103
False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
Wolters, T., van der Kwast, T., Vissers, C. J., Bangma, C. H., Roobol, M. J., Schröder, F. H., & van Leenders, G. J. L. H. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181c3ece9 · Cited by 88
Hendriks, R. J., Dijkstra, S., Jannink, S. A., Steffens, M. G., van Oort, I. M., Mulders, P., & Schalken, J. A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0599 · Cited by 66
Self-citation
Cited by
Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators
Van Calster, B., Wynants, L., Verbeek, J. F. M., Verbakel, J. Y., Christodoulou, E., Vickers, A. J., Roobol, M. J., & Steyerberg, E. W. (2018) · European Urology · doi:10.1016/j.eururo.2018.08.038 · Cited by 1,271
Genomic Markers in Prostate Cancer Decision Making
Cucchiara, V., Cooperberg, M. R., Dall’Era, M., Lin, D. W., Montorsi, F., Schalken, J. A., & Evans, C. P. (2018) · European Urology · doi:10.1016/j.eururo.2017.10.036 · Cited by 269
Self-citationBiomarkers for prostate cancer: prostate-specific antigen and beyond
Duffy, M. J. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0693 · Cited by 267
miRNAs as therapeutic tools and biomarkers for prostate cancer
Arrighetti, N., & Beretta, G. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030380 · Cited by 43
Kaufman, S. R., Yoganathan, P., Small, K. W., Rusia, D., Pachydaki, S. I., Conti, S. M., Wenz, R. E., Gersman, M. A., Shaya, F. S., & Kustra, R. (2021) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126420941713 · Cited by 1
“One alternate approach to assess whether there is an interaction between 2 independent variables is a case-only design, the validity of which has been established.(19,20) Unlike a casecontrol study, in which exposures are compared between individuals with a condition and those without, a case-only study evaluates only…”
Background
Metadata
- Authors
- Van Neste, L., Hendriks, R. J., Dijkstra, S., Trooskens, G., Cornel, E. B., Jannink, S. A., de Jong, H., Hessels, D., Smit, F. P., Melchers, W. J. G., Leyten, G. H. J. M., de Reijke, T. M., Vergunst, H., Kil, P., Knipscheer, B. C., Hulsbergen-van de Kaa, C. A., Mulders, P. F. A., van Oort, I. M., Van Criekinge, W., & Schalken, J. A.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 70
- Issue
- 5
- Pages
- 740-748
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2341689870
- Cited by
- 370
- References
- 27
- FWCI
- 31.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.